FI910816A0 - Förfarande för framställning av nya terapeutiskt användbara 3H,6H-1,4,5a,8a-tetraazaacenaftylen-3,5(4H)-dionderivat - Google Patents
Förfarande för framställning av nya terapeutiskt användbara 3H,6H-1,4,5a,8a-tetraazaacenaftylen-3,5(4H)-dionderivatInfo
- Publication number
- FI910816A0 FI910816A0 FI910816A FI910816A FI910816A0 FI 910816 A0 FI910816 A0 FI 910816A0 FI 910816 A FI910816 A FI 910816A FI 910816 A FI910816 A FI 910816A FI 910816 A0 FI910816 A0 FI 910816A0
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- tetraazaacenaphthylene
- preparation
- therapeutically useful
- hydrogen
- Prior art date
Links
- WABFHIRTWFQGJP-UHFFFAOYSA-N 1,2,6,8-tetrazatricyclo[6.3.1.04,12]dodeca-2,4(12),10-triene-5,7-dione Chemical class C1=CCN2C(=O)NC(=O)C3=C2N1N=C3 WABFHIRTWFQGJP-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- -1 carboxamidomethyl Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/16—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Photoreceptors In Electrophotography (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48256890 | 1990-02-21 | ||
| US07/482,568 US5013737A (en) | 1988-02-22 | 1990-02-21 | 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI910816A0 true FI910816A0 (sv) | 1991-02-20 |
| FI910816L FI910816L (sv) | 1991-08-22 |
| FI93963B FI93963B (sv) | 1995-03-15 |
| FI93963C FI93963C (sv) | 1995-06-26 |
Family
ID=23916572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI910816A FI93963C (sv) | 1990-02-21 | 1991-02-20 | Förfarande för framställning av nya terapeutiskt användbara 3H,6H-1,4,5a,8a-tetraazaacenaftylen-3,5(4H)-dionderivat |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5013737A (sv) |
| EP (1) | EP0443312B1 (sv) |
| JP (1) | JP3046851B2 (sv) |
| KR (1) | KR0183395B1 (sv) |
| AT (1) | ATE152723T1 (sv) |
| AU (1) | AU640202B2 (sv) |
| CA (1) | CA2036589A1 (sv) |
| CZ (1) | CZ285584B6 (sv) |
| DE (1) | DE69125962T2 (sv) |
| DK (1) | DK0443312T3 (sv) |
| ES (1) | ES2102371T3 (sv) |
| FI (1) | FI93963C (sv) |
| GR (1) | GR3024063T3 (sv) |
| HU (1) | HUT60500A (sv) |
| IE (1) | IE910575A1 (sv) |
| IL (1) | IL97289A (sv) |
| NO (1) | NO177749C (sv) |
| NZ (1) | NZ237123A (sv) |
| PH (1) | PH27464A (sv) |
| PL (1) | PL166100B1 (sv) |
| PT (1) | PT96805B (sv) |
| SG (1) | SG47638A1 (sv) |
| SK (1) | SK279997B6 (sv) |
| ZA (1) | ZA911260B (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002529465A (ja) * | 1998-11-12 | 2002-09-10 | ニューロクライン バイオサイエンシーズ， インコーポレイテッド | Ｃｒｆレセプターアンタゴニストおよびｃｒｆレセプターアンタゴニストに関する方法 |
| CA2349904A1 (en) * | 1998-11-12 | 2000-05-18 | Neurocrine Biosciences, Inc. | Crf receptor antagonists and methods relating thereto |
| EP1996594A2 (en) * | 2006-03-17 | 2008-12-03 | Wyeth a Corporation of the State of Delaware | Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof |
| US20070219183A1 (en) * | 2006-03-17 | 2007-09-20 | Wyeth | Dihydropyrazolo[1,5-A]pyrimidine and dihydroimidazo[1,5-A]pyrimidine derivatives and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4178449A (en) * | 1978-04-17 | 1979-12-11 | American Cyanamid Company | Pyrazolo[1,5-a]pyrimidines and imidazo-[1,5-a]pyrimidines |
| US4236005A (en) * | 1979-07-02 | 1980-11-25 | American Cyanamid Company | Imidazo[1,5-a]pyrimidines |
| US4281000A (en) * | 1979-07-09 | 1981-07-28 | American Cyanamid Company | Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents |
| US4713383A (en) * | 1984-10-01 | 1987-12-15 | Ciba-Geigy Corporation | Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses |
| US4614732A (en) * | 1984-10-26 | 1986-09-30 | Warner-Lambert Company | N6 -acenaphthyl adenosines and analogs thereof |
| ATE99686T1 (de) * | 1988-02-22 | 1994-01-15 | American Cyanamid Co | 5-(substituierte amino)-8-(phenyl oder substituierte phenyl)-3h,6h-1,4,5a,8atetraazaacenaphthylen-3-one. |
-
1990
- 1990-02-21 US US07/482,568 patent/US5013737A/en not_active Expired - Lifetime
-
1991
- 1991-01-08 EP EP91100189A patent/EP0443312B1/en not_active Expired - Lifetime
- 1991-01-08 SG SG1996003303A patent/SG47638A1/en unknown
- 1991-01-08 ES ES91100189T patent/ES2102371T3/es not_active Expired - Lifetime
- 1991-01-08 DE DE69125962T patent/DE69125962T2/de not_active Expired - Fee Related
- 1991-01-08 AT AT91100189T patent/ATE152723T1/de not_active IP Right Cessation
- 1991-01-08 DK DK91100189.9T patent/DK0443312T3/da active
- 1991-02-14 NZ NZ23712391A patent/NZ237123A/en unknown
- 1991-02-19 CA CA002036589A patent/CA2036589A1/en not_active Abandoned
- 1991-02-19 PT PT96805A patent/PT96805B/pt not_active IP Right Cessation
- 1991-02-19 CZ CS91419A patent/CZ285584B6/cs not_active IP Right Cessation
- 1991-02-19 PH PH42023A patent/PH27464A/en unknown
- 1991-02-19 JP JP3045452A patent/JP3046851B2/ja not_active Expired - Lifetime
- 1991-02-19 SK SK419-91A patent/SK279997B6/sk unknown
- 1991-02-20 KR KR1019910002713A patent/KR0183395B1/ko not_active Expired - Fee Related
- 1991-02-20 IE IE057591A patent/IE910575A1/en not_active Application Discontinuation
- 1991-02-20 ZA ZA911260A patent/ZA911260B/xx unknown
- 1991-02-20 NO NO910686A patent/NO177749C/no not_active IP Right Cessation
- 1991-02-20 FI FI910816A patent/FI93963C/sv active
- 1991-02-20 AU AU71225/91A patent/AU640202B2/en not_active Ceased
- 1991-02-20 IL IL9728991A patent/IL97289A/en not_active IP Right Cessation
- 1991-02-21 PL PL91289157A patent/PL166100B1/pl unknown
- 1991-02-21 HU HU91584A patent/HUT60500A/hu unknown
-
1997
- 1997-07-09 GR GR970401719T patent/GR3024063T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG105550A (en) | 2-pheylbenzimidazoles and 2-phenylindoles, and production and use thereof | |
| CA2236814A1 (en) | Quinoline and quinazoline compounds useful in therapy | |
| FI904327A0 (fi) | N-substituerad-4-pyrimidinaminer och -pyrimidindiaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| ES8205771A1 (es) | Un procedimiento para la obtencion de un derivado acilado sustituido de acido octahidro-1h-indol-2-carboxilico | |
| ATE255563T1 (de) | Therapeutisch nützliche chinoline und quinazoline | |
| GB1063384A (en) | Substituted 3-haloacetyl indoles | |
| NO913292L (no) | Fremgangsmaate og anvendelse av 6,7-dihydro-3-fenyl-1,2-benzisoksazol-4(5h)-oner og -oler. | |
| BR8907772A (pt) | Composto,processo de controle de vegetacao indesejavel e composicao herbicida | |
| DE3767778D1 (de) | Entzuendung verhindernde und allergie heilende mittel. | |
| AU7810787A (en) | 6-{2-(3-phenoxy-2-hydroxy-propylamino)-propyl-amino}-5- methyl-pyrizine-3-one derivatives useful as antihyper- tensive agents | |
| BR9801506A (pt) | Compostos de quinolina e quinazolina úteis em terapia. | |
| ATE107633T1 (de) | Pyrimidinon-derivate. | |
| FI910816A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara 3H,6H-1,4,5a,8a-tetraazaacenaftylen-3,5(4H)-dionderivat | |
| MA22816A1 (fr) | Nouveaux arylindazoles et leur emploi en tant qu'herbicides. | |
| DK0480155T3 (da) | 4-Substituerede dihydropyrido(4,3-d)pyrimidiner som analgetica og topiske antiinflammatoriske midler til behandling af hudlidelser | |
| NO995289L (no) | Benzimidazol-derivater | |
| GR78617B (sv) | ||
| DK0573464T3 (da) | Fremgangsmåde til fremstilling af trans-piperidin-2,5-dicarboxylater | |
| FI852249A0 (fi) | Foerfarande foer framstaellning av nya isoxazolokinolinoner. | |
| ES2056121T3 (es) | 3-arilcarbamoil-5-aminometil-oxazolidinas asi como sus sales con acidos farmaceuticamente compatibles. | |
| IT1296065B1 (it) | 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione | |
| IT1298421B1 (it) | 2-(2'-idrossifenil) benzotriazoli e procedimento per la loro preparazione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application |